Downregulation of cyclin D1 sensitizes cancer cells to MDM2 antagonist Nutlin-3
Peipei Yang(Zhejiang Sci-Tech University), Wen‐Bin Ou(Brigham and Women's Hospital)
Cited by 21
Related Papers
Anaplastic lymphoma kinase fusions: Roles in cancer and therapeutic perspectives (Review)
|Oncology Letters|2018|55
HDACi inhibits liposarcoma via targeting of the MDM2-p53 signaling axis and PTEN, irrespective of p53 mutational status
|Oncotarget|2015|37
YWHAE-NUTM2 oncoprotein regulates proliferation and cyclin D1 via RAF/MAPK and Hippo pathways
|Oncogenesis|2021|35
Co-targeting of FAK and MDM2 triggers additive anti-proliferative effects in mesothelioma via a coordinated reactivation of p53
|British Journal of Cancer|2016|33